Message Font: Serif | Sans-Serif
No. of Recommendations: 5

PALO ALTO, Calif. and SAN DIEGO, Aug. 1 /PRNewswire/ -- Incyte Genomics, Inc. (Nasdaq: INCY - news), the leading genomic information company, and Corvas International, Inc. (Nasdaq: CVAS - news), a clinical-stage biopharmaceutical company, today announced the signing of a multi-year subscription for Incyte's industry leading LifeSeq® Gold database to advance Corvas' cancer research and development programs focused on serine proteases, a class of potential solid tumor drug targets. Financial terms were not disclosed.

Why would Corvas choose LifeSeq when they could use Celera's products?
Hmm, maybe this is why.

PALO ALTO, Calif., Aug. 2 /PRNewswire/ -- Incyte Genomics, the leading genomics information company, today announced that its respected database -- LifeSeq Gold® -- won Scientific Computing & Instrumentation's 10th annual Readers' Choice Award for Bioinformatics software. This is the second consecutive year LifeSeq Gold® has won the award.

``SC&I's Readers' Choice Awards recognize products used by a highly educated and experienced pool of scientists and technical professionals. These products have been chosen based on their high level of reliability and quality, as well as their ability to enhance productivity and innovation,' said Editor-in-Chief Kim Sekel.

Print the post  


What was Your Dumbest Investment?
Share it with us -- and learn from others' stories of flubs.
When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.